학술논문

MUTUAL STUDY BY USING NEXT GENERATION SEQUENCING (NGS) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) HIGH RISK AND SECONDARY ACUTE MYELOID LEUKEMIA (SAML) HYPOMETHYLATING DRUG TREATED WITH ACCORDING TO THE PROTOCOL FROM THE CETLAM GROUP IN HIGH RISK SMD (2009)
Document Type
Journal
Source
HAEMATOLOGICA; OCT 2016, 101 p242-p242, 1p. Supplement: 4
Subject
Language
Spanish
ISSN
03906078